4//SEC Filing
AFEYAN NOUBAR 4
Accession 0001193125-25-318567
CIK 0001682852other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 9:00 AM ET
Size
12.1 KB
Accession
0001193125-25-318567
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
AFEYAN NOUBAR
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-11$10.90/sh+23,853$259,998→ 27,777 total(indirect: By Flagship Pioneering, Inc.) - Sale
Common Stock
2025-12-11$29.48/sh−23,853$703,306→ 3,924 total(indirect: By Flagship Pioneering, Inc.) - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-11−23,853→ 0 total(indirect: By Flagship Pioneering, Inc.)Exercise: $10.90Exp: 2026-02-23→ Common Stock (23,853 underlying)
Holdings
- 3,880,328(indirect: By Flagship Ventures Fund IV, L.P.)
Common Stock
- 747,897(indirect: By Flagship Ventures Fund IV-Rx, L.P.)
Common Stock
- 2,224,015
Common Stock
Footnotes (5)
- [F1]On December 11, 2025, Flagship Pioneering, Inc. ("Flagship Pioneering") exercised options to purchase 23,853 shares of the Issuer's Common Stock at $10.90 per share, which options were set to expire on February 23, 2026.
- [F2]The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the CEO and sole stockholder of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- [F3]The securities are held directly by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. The reporting person is the sole manager of Flagship Fund IV GP and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- [F4]The securities are held directly by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- [F5]The options were fully vested and exercisable.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001222012
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 9:00 AM ET
- Size
- 12.1 KB